IL66338A - Anti-cancer drugs comprising platinum complexed antitumor immunoglobulins - Google Patents

Anti-cancer drugs comprising platinum complexed antitumor immunoglobulins

Info

Publication number
IL66338A
IL66338A IL66338A IL6633882A IL66338A IL 66338 A IL66338 A IL 66338A IL 66338 A IL66338 A IL 66338A IL 6633882 A IL6633882 A IL 6633882A IL 66338 A IL66338 A IL 66338A
Authority
IL
Israel
Prior art keywords
immunoglobulins
platinum
antitumor
immunoglobulin
tumor
Prior art date
Application number
IL66338A
Other languages
English (en)
Other versions
IL66338A0 (en
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Priority to IL66338A priority Critical patent/IL66338A/xx
Publication of IL66338A0 publication Critical patent/IL66338A0/xx
Priority to CA000432233A priority patent/CA1224718A/fr
Priority to AU16858/83A priority patent/AU555324B2/en
Priority to EP83106965A priority patent/EP0099133B1/fr
Priority to JP58128057A priority patent/JPS59130222A/ja
Priority to DE8383106965T priority patent/DE3378524D1/de
Priority to AT83106965T priority patent/ATE38775T1/de
Publication of IL66338A publication Critical patent/IL66338A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6883—Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
IL66338A 1982-07-15 1982-07-15 Anti-cancer drugs comprising platinum complexed antitumor immunoglobulins IL66338A (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IL66338A IL66338A (en) 1982-07-15 1982-07-15 Anti-cancer drugs comprising platinum complexed antitumor immunoglobulins
CA000432233A CA1224718A (fr) 1982-07-15 1983-07-12 Agents antitumoraux contenant des complexes du platine
AU16858/83A AU555324B2 (en) 1982-07-15 1983-07-14 Platinum-anti-tumor immunoglobulin complexes
EP83106965A EP0099133B1 (fr) 1982-07-15 1983-07-15 Médicaments contre le cancer, comprenant des complexes de platine
JP58128057A JPS59130222A (ja) 1982-07-15 1983-07-15 抗−腫瘍剤及びその調整方法
DE8383106965T DE3378524D1 (en) 1982-07-15 1983-07-15 Anti-cancer drugs comprising platinum complexes
AT83106965T ATE38775T1 (de) 1982-07-15 1983-07-15 Platinkomplexe enthaltende antikrebsarzneimittel.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL66338A IL66338A (en) 1982-07-15 1982-07-15 Anti-cancer drugs comprising platinum complexed antitumor immunoglobulins

Publications (2)

Publication Number Publication Date
IL66338A0 IL66338A0 (en) 1982-11-30
IL66338A true IL66338A (en) 1986-03-31

Family

ID=11053640

Family Applications (1)

Application Number Title Priority Date Filing Date
IL66338A IL66338A (en) 1982-07-15 1982-07-15 Anti-cancer drugs comprising platinum complexed antitumor immunoglobulins

Country Status (7)

Country Link
EP (1) EP0099133B1 (fr)
JP (1) JPS59130222A (fr)
AT (1) ATE38775T1 (fr)
AU (1) AU555324B2 (fr)
CA (1) CA1224718A (fr)
DE (1) DE3378524D1 (fr)
IL (1) IL66338A (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0167310B1 (fr) * 1984-06-27 1991-05-29 Johnson Matthey Public Limited Company Composés de coordination du platine
US4952676A (en) * 1984-06-27 1990-08-28 Johnson Matthey Plc Monoclonal antibody-platinum co-ordination compound complex
US4956454A (en) * 1984-06-27 1990-09-11 Johnson Matthey Plc Monoclonal antibody - platinum co-ordination compound complex
EP0169645A1 (fr) * 1984-06-27 1986-01-29 Johnson Matthey Public Limited Company Composés de coordination du platine
US5100877A (en) * 1986-05-21 1992-03-31 Kuraray Co., Ltd. Platinum containing pullulan derivatives and pharmaceutical compositions comprising the same
WO1987007142A1 (fr) * 1986-05-21 1987-12-03 Kuraray Co., Ltd. Nouveaux complexes, procede pour leur preparation, et leur emploi medicinal
US4793986A (en) * 1987-02-25 1988-12-27 Johnson Matthey, Inc. Macromolecular platinum antitumor compounds
JP2520262B2 (ja) * 1987-08-21 1996-07-31 春幸 川原 パツチテスト材料
CN104934660B (zh) * 2015-07-14 2017-03-01 北京航空航天大学 一种便捷卷式超薄氧‑金属电池
CN117383616B (zh) * 2023-10-13 2024-11-01 广东医科大学 一种中空载药纳米酶、制备方法及抗肿瘤药物

Also Published As

Publication number Publication date
DE3378524D1 (en) 1988-12-29
ATE38775T1 (de) 1988-12-15
IL66338A0 (en) 1982-11-30
CA1224718A (fr) 1987-07-28
JPS59130222A (ja) 1984-07-26
EP0099133A3 (en) 1984-09-05
AU555324B2 (en) 1986-09-18
AU1685883A (en) 1984-01-19
EP0099133A2 (fr) 1984-01-25
EP0099133B1 (fr) 1988-11-23

Similar Documents

Publication Publication Date Title
IL47372A0 (en) Fab'dimers bound to anti-cancer drugs
EP0287317A3 (fr) Complexes de platine avec un ligand sensible au radiation
IL66338A (en) Anti-cancer drugs comprising platinum complexed antitumor immunoglobulins
KE3590A (en) Platinum-diamine complexes,a method for the preparation thereof,a method for the preparation of a medicine using such a platinum-diamine complex for the treatment of cancer,as well as a medicine thus formed
AU559983B2 (en) Platinum complexes, treatment of cancer
BE895990A (fr) Preparation de complexes de nickel de valence zero
ES8604070A1 (es) Un metodo para preparar un complejo platinoso
IL75361A0 (en) Tumor cell growth-inhibiting pharmaceutical compositions containing phosphino-hydrocarbon-gold,silver or copper complexes
HUT40452A (en) Process for preparing tumor inhibiting (1-benzyl-ethylene-diamine)-platinum(ii) complexes
US4536386B1 (en) Method of controlling emesis caused by cisplatin in cancer chemotherapy
IE850226L (en) Antitumor compositions employing £x, w-bis (disubstituted¹phosphino) - hydrocarbon|digold, disilverand dicopper¹derivatives
NL189965C (nl) Triarylboraanisocyanometaalcomplexen.
DE3577709D1 (de) Platin-intercalativ-komplexe zur behandlung von krebs.
DE3578180D1 (de) Aminoanthracendione-platin-komplexe fuer anti-krebs-verbindungen.
GB2131020B (en) Improvements relating to compounds useful in radiotherapy or chemotherapy
ZA854905B (en) Cis-platinum(ii)complexes with diamino-sugar derivatives as ligands,processes for their preparation and medicaments containing these complexes
HUT39323A (en) Herbicides and fungicides containing as reagent derivatives of tetrahydro-kynolin-1-il-carbonil-imidazol and process for production of the reagent
GB1166110A (en) Substituted Thiocyano Pyrroles, Fungicidal preparations containing these Compounds as Active Ingredients and methods of using the same
DE3572979D1 (en) Treatment of hydrocarbon solutions of dialkylmagnesium compounds to reduce the content of soluble chloridecontaining complexes
DE3379465D1 (en) Substituted cyclopentadienyl cobalt complexes and synthesis of pyridine homologues by means of the complexes
ZA855862B (en) Amino-anthracenediones-platinum complexes useful as anti-cancer compounds
JPS57159798A (en) Cis-platinum(ii) complex compound having saccharides derivative as ligand
AU1895583A (en) Ce diketonate complexes
DK349384A (da) Ph-regulerende fodertilskud
GB2165046B (en) Ligand molecule